Edgewater, NJ, United States of America

Hideyuki Igawa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Cornell University, Tri-Institutional Therapeutics Discovery Institute. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideyuki Igawa. Retrieved from https://idiyas.com/inventor/hideyuki-igawa-tzssmrgh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideyuki Igawa

Introduction

Hideyuki Igawa is a notable inventor based in Edgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. His work is characterized by a focus on innovative chemical structures and their applications in treating diseases.

Latest Patents

Igawa holds a patent for "Pyridinone- and pyridazinone-based compounds and uses thereof." This patent describes compounds of the formula A-L-Het-L-Cy, or a pharmaceutical acceptable salt, polymorph, prodrug, solvate, or clathrate thereof. The compounds are designed to be useful in the treatment of fibrotic diseases, abnormal vascular leak, and pathological angiogenesis. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Igawa has worked with prestigious institutions such as Cornell University and the Tri-Institutional Therapeutics Discovery Institute. His research has contributed to advancements in pharmaceutical science, particularly in the development of new therapeutic agents.

Collaborations

Igawa has collaborated with notable colleagues, including Asato Kina and Ayumu Sato. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Hideyuki Igawa's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health issues through scientific research. His work continues to influence the development of new treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…